Savara Ownership | Who Owns Savara?
Savara Ownership Summary
Savara is owned by 77.43% institutional investors, 5.38% insiders, and 17.19% retail investors. Nea management company is the largest institutional shareholder, holding 11.31% of SVRA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.95% of its assets in Savara shares.
SVRA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Savara | 77.43% | 5.38% | 17.19% |
| Sector | Healthcare Stocks | 218.58% | 11.00% | -129.58% |
| Industry | Biotech Stocks | 296.15% | 10.91% | -207.06% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Nea management company | 24.47M | 11.31% | $55.79M |
| Bain capital life sciences investors | 17.60M | 8.13% | $40.13M |
| Tcg crossover management | 12.36M | 5.71% | $28.19M |
| Frazier life sciences management | 11.46M | 5.30% | $26.13M |
| Vestal point capital, lp | 11.02M | 5.09% | $25.11M |
| Blackrock funding, inc. /de | 9.78M | 4.52% | $22.29M |
| Blackrock | 8.03M | 4.40% | $32.36M |
| Vr adviser | 8.88M | 4.10% | $20.26M |
| Vanguard group | 8.31M | 3.92% | $25.51M |
| Nantahala capital management | 8.33M | 3.85% | $18.98M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Bain capital life sciences investors | 17.60M | 5.02% | $40.13M |
| Nea management company | 24.47M | 4.20% | $55.79M |
| Rosalind advisors | 2.65M | 4.17% | $8.15M |
| Tcg crossover management | 12.36M | 3.22% | $28.19M |
| Superstring capital management lp | 1.12M | 3.01% | $2.54M |
| Vr adviser | 8.88M | 1.52% | $20.26M |
| Ghost tree capital | 1.05M | 1.33% | $4.24M |
| Vestal point capital, lp | 11.02M | 1.32% | $25.11M |
| Adar1 capital management | 3.60M | 1.26% | $8.21M |
| Frazier life sciences management | 11.46M | 1.05% | $26.13M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vr adviser | 8.88M | 1.52% | 5.63M |
| Rosalind advisors | 2.65M | 4.17% | 2.65M |
| Adar1 capital management | 3.60M | 1.26% | 2.24M |
| State street | 3.58M | 0.00% | 1.70M |
| Jpmorgan chase | 1.42M | 0.00% | 1.35M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Jennison associates | - | - | -6.73M |
| Wellington management group llp | 5.48M | 0.00% | -3.14M |
| Sofinnova investments | 2.46M | 0.34% | -3.02M |
| Adage capital partners gp | - | - | -2.12M |
| Vivo capital | - | - | -2.09M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Rosalind advisors | 2.65M | 4.17% | 2.65M | $8.15M |
| Driehaus capital management | 182.30K | 0.00% | 182.30K | $415.63K |
| Susquehanna portfolio strategies | 39.84K | 0.00% | 39.84K | $90.83K |
| Los angeles capital management | 30.39K | 0.00% | 30.39K | $69.30K |
| Quadrature capital | 18.46K | 0.00% | 18.46K | $41.99K |
Sold Out
| Holder | Change |
|---|---|
| Federated hermes | -3.00 |
| Nelson, van denburg & campbell wealth management group | -16.00 |
| Natixis | -20.00 |
| Signaturefd | -30.00 |
| Gamma investing | -60.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 122 | -10.95% | 167,584,407 | 1.51% | 77 | 1.33% | 60 | -13.04% | 35 | -10.26% |
| Mar 31, 2025 | 12 | -91.18% | 67,904,042 | -58.30% | 34 | 0.58% | 10 | -87.50% | 1 | -96.88% |
| Dec 31, 2024 | 39 | -69.53% | 26,754,956 | -83.33% | 12 | 0.22% | 21 | -71.62% | 8 | -69.23% |
| Sep 30, 2024 | 128 | -11.72% | 160,502,555 | 8.32% | 75 | 1.15% | 74 | -15.91% | 26 | -10.34% |
| Jun 30, 2024 | 145 | 16.94% | 148,180,451 | 22.39% | 81 | 1.85% | 88 | 8.64% | 29 | 26.09% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 5.10M | 2.95% | -113.17K |
| Vanguard US Total Market Shares ETF | 4.93M | 2.86% | - |
| Jennison Health Sciences Equity | 3.78M | 2.29% | 463.66K |
| PGIM Jennison Health Sciences Z | 3.78M | 2.21% | - |
| iShares Russell 2000 ETF | 2.97M | 1.72% | -56.38K |
| SPDR® S&P Biotech ETF | 1.56M | 0.91% | -9.50K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.26M | 0.73% | -574.05K |
| Fidelity Small Cap Index | 1.23M | 0.71% | - |
| iShares Russell 2000 Growth ETF | 1.14M | 0.66% | - |
| UTM IM GBP AXA Framlington Biotech | 1.01M | 0.58% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 20, 2025 | Hawkins Richard J | - | Buy | $98.57K |
| May 29, 2025 | McCracken Joseph S | - | Buy | $20.82K |
| Mar 31, 2025 | RAMSAY DAVID A | - | Buy | $416.25K |
| Dec 16, 2024 | Lowrance David L | Chief Financial Officer | Sell | $83.28K |
| Dec 16, 2024 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | Sell | $180.83K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | 1 | - |
| 2024 Q4 | 2 | 3 |
| 2024 Q3 | - | - |
| 2024 Q2 | - | - |
| 2024 Q1 | - | - |
SVRA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools